Shay Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-35,635
Closed -$561K 572
2022
Q2
$561K Buy
35,635
+10,335
+41% +$158K 0.11% 179
2022
Q1
$385K Buy
+25,300
New +$385K 0.05% 275
2021
Q4
Sell
-145,000
Closed -$1.26M 721
2021
Q3
$1.26M Buy
145,000
+40,000
+38% +$365K 0.16% 138
2021
Q2
$1.07M Buy
105,000
+74,000
+239% +$781K 0.12% 153
2021
Q1
$370K Sell
31,000
-60,500
-66% -$686K 0.04% 280
2020
Q4
$832K Buy
+91,500
New +$708K 0.18% 116

Other funds holding NPTN

Shay Capital's NPTN Position: Q3 2022 in Review

Shay Capital sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 35,635 shares — an estimated $561K sold.

Shay Capital first reported a position in NPTN in Q4 2020 and held it in 6 quarters. The position peaked at $1.26M in Q3 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Shay Capital reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Shay Capital sold 35,635 NEOPHOTONICS CORP shares in Q3 2022, an estimated $561K.
  • Shay Capital first reported a position in NEOPHOTONICS CORP in Q4 2020 and held it in 6 quarters.
  • Shay Capital's NEOPHOTONICS CORP position peaked at $1.26M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Shay Capital's 13F filing for Q3 2022, filed 14 Nov 2022.